Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

I could not disagree more. They have money

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Runninonempty Member Profile
 
Followed By 0
Posts 88
Boards Moderated 0
Alias Born 11/03/17
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/2/2019 4:06:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/2/2019 10:22:49 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/27/2019 4:38:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/26/2019 4:32:06 PM
Bio-Path Holdings Announces Successful Completion of Safety Testing in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leu... GlobeNewswire Inc. - 11/26/2019 8:00:10 AM
Bio-Path Holdings Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/25/2019 2:11:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2019 5:26:35 PM
Bio-Path Holdings Announces $8.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/21/2019 11:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2019 8:21:07 AM
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 GlobeNewswire Inc. - 11/21/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2019 7:08:27 AM
Bio-Path Holdings Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/15/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:25:09 PM
Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019 GlobeNewswire Inc. - 11/8/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/1/2019 4:49:22 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/1/2019 4:46:18 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/22/2019 5:06:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 4:24:51 PM
Bio-Path Holdings Appoints Martina Molsbergen to Board of Directors GlobeNewswire Inc. - 10/15/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2019 5:17:26 PM
Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Technology Patent GlobeNewswire Inc. - 9/25/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 4:07:11 PM
Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 9/3/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2019 6:02:06 AM
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia GlobeNewswire Inc. - 8/26/2019 7:00:00 AM
Runninonempty   Thursday, 06/13/19 12:32:51 PM
Re: None
Post # of 6229 
I could not disagree more. They have money for two plus years right now. More good news will come before then and the dilution will be much less with raising money after that news. We have had enough of selling stock at low prices for now. However, in your defense, I think PN sadly may do exactly what you suggest:(

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist